The perception of medical value of most new products goes through a series of stages from unrealistic optimism to unrealistic pessimism and eventually to a balanced view.
Time is generally viewed in drug development as the single most precious resource you have to spend.
There is a spectrum for discovering drugs that ranges from purely rational to that of pure chance or serendipity.
Bert Spilker, PhD, MD is an independent consultant who was most recently the Senior Vice President of Scientific and Regulatory Affairs for PhRMA. He is the founder of Bert Spilker & Associates (BS&A).
